ARCHIVES

NIH Probing: Double Dipping” Allegation

This article is from The Cancer Letter archive.

Vol. 07 No. 36 | September 4, 1981

Download PDF Visit The Full Archive

Related Articles

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012